MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 7, 2007; DOI: 10.1124/mol.107.038323


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.038323v1
73/2/498    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Papucci, L.
Right arrow Articles by Capaccioli, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papucci, L.
Right arrow Articles by Capaccioli, S.


Received for publication May 22, 2007.
Revised November 6, 2007.
Accepted for publication November 6, 2007.

Impact of targeting the AU-rich element of bcl-2 mRNA with oligoribonucleotides on apoptosis, cell cycle and neuronal differentiation in SHSY-5Y cells

Laura Papucci 1, Ewa Witort 1, Annamaria Bevilacqua 2, Martino Donnini 1, Matteo Lulli 1, Elisabetta Borchi 1, Khalid S.A. Khabar 3, Alessio Tempestini 1, Andrea Lapucci 1, Nicola Schiavone 1*, Angelo Nicolin 2, Sergio Capaccioli 1

1 Department of Experimental Pathology and Oncology, University of Florence, Italy 2 Department of Pharmacology, University of Milan, Italy 3 Program in Biomolecular Research, King Faisal Specialist Hospital and Research Center, Riyadh 11211

* Address correspondence to: E-mail: nicola{at}unifi.it

Abstract

We have previously identified a destabilizing AU-rich element (ARE) in the 3'UTR of bcl-2 mRNA that interacted with ARE-binding proteins (AUBPs) to down-regulate bcl-2 gene expression in response to apoptotic stimuli. We have also described three contiguous 2'-O-methyl oligoribonucleotides both in sense and in antisense orientation with respect to the bcl-2 ARE that are able to regulate the bcl-2 mRNA half-life and Bcl-2 protein level in two different cell lines. Here we show that treatment of neuronal cell line (SHSY-5Y) with antisense ORNs targeting the bcl-2 ARE (bcl-2 ARE asORNs) prevents bcl-2 down-regulation in response to apoptotic stimuli with glucose/growth factor starvation (Locke medium) or oxygen deprivation, and enhances the apoptotic threshold as evaluated by Time lapse videomicroscopy, FACS analysis and caspase-3 activation. Additional effects of bcl-2 ARE asORNs included inhibition of cell cycle entry and a marked increase of cellular neurite number and length, a hallmark of neuronal differentiation resulting from bcl-2 up-regulation. The ability of bcl-2 ARE asORNs to enhance the apoptotic threshold and to induce neuronal differentiation implies their potential application as a novel informational tool to protect cells from ischemic damage and to prevent neuronal degeneration.


Key words: Antisense, Mechanisms of cell killing/apoptosis





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics